Article Text

Download PDFPDF
St John's wort was no better than placebo for reducing depression scores

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 QUESTION: In patients with major depression, is St John's wort (Hypericum extract) better than placebo for reducing depressive symptoms?

Design

Randomised (allocation concealed*), blinded {clinicians, patients, outcome assessors, and statisticians},* placebo controlled trial with 8 weeks of follow up.

Setting

11 academic medical centres in the USA.

Patients

200 physically healthy outpatients who were ≥ 18 years of age (mean age 42.4 y, 64% women); had major depression (single episode or recurrent) without psychotic features according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition for ≥ 4 weeks; and scored ≥ 20 on the Hamilton Depression Rating Scale (HDRS). Exclusion criteria included having cognitive, post-traumatic stress, eating, or substance use disorders in the previous 6 months; panic disorder in the previous year; and bipolar, psychotic, or primary personality disorders. Patients who improved during the 1 week placebo run-in period were …

View Full Text

Footnotes

  • Sources of funding: Pfizer Inc. and National Institute of Mental Health.

  • For correspondence: Dr R C Shelton, 1500 21st Avenue South, Suite 2200, Nashville, TN 37212, USA. Fax +1 615 343 9038.

  • Abstract and commentary also appear in Evidence-Based Mental Health.

  • * See glossary.

  • Information provided by author.